MERAND PHARMACEUTICALS
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease. Merand's therapeutic treats patients by promoting angiogenesis or the development of new blood vessels, which leads to restored blood flow, enabling doctors to stabilize functional blood vessels of patients to increase perfusion recovery and reduce inflammation.
MERAND PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
CAV Angels
CAV Angels investment in Seed Round - Merand Pharmaceuticals
Charlottesville Angel Network
Charlottesville Angel Network investment in Seed Round - Merand Pharmaceuticals
UVA Licensing & Ventures Group
UVA Licensing & Ventures Group investment in Seed Round - Merand Pharmaceuticals
More informations about "Merand Pharmaceuticals"
Merand Pharmaceuticals Inc.
Dr. Nwachuku is the most recent member of the Merand management team, joining the Company in 2020. He is an alumnus of the NIH and was the Scientific Project Officer for the ALLHAT trial. In the biopharmaceutical Industry, Dr. …See details»
About us - Merand Pharmaceuticals Inc.
Founded in 2018, Merand Pharmaceuticals, Inc. is a clinical stage, privately held corporation (Delaware registered), which is developing microRNAs for unmet clinical needs in patients with vascular diseases.Its first product will target …See details»
Merand Pharmaceuticals - Crunchbase Company Profile & Funding
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease. Merand's therapeutic treats patients by promoting angiogenesis or the development of new …See details»
Merand Pharma - PitchBook
Merand Pharma General Information Description. Developer of microRNA therapeutics designed to treat patients suffering from peripheral arterial disease. The company's therapeutics treat …See details»
Merand Pharmaceuticals - Funding, Financials, Valuation & Investors
Merand Pharmaceuticals has raised 1 round. This was a Seed round raised on Jul 31, 2019. Merand Pharmaceuticals is funded by 3 investors. CAV Angels and Charlottesville Angel …See details»
MERAND PHARMACEUTICALS, INC.
Assignee: Merand Pharmaceuticals, Inc. Provision patent application US 63/148,940 filed on 2/12/2021 INTELLECTUAL PROPERTY Broad Protection for Treating PAD 12. D …See details»
Merand Pharmaceuticals - Updates, News, Events, Signals & Triggers
Jul 31, 2019 Organization. Merand Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Recent News & Activity. …See details»
Merand Pharmaceuticals, Inc. - fund raising filing
Jul 23, 2019 Merand Pharmaceuticals, Inc. - Most recent fund raising on July 23, 2019 raised $1,135,000 in Equity. FormDs.com . Newest; Filter; Local; Merand Pharmaceuticals, Inc. …See details»
Merand Pharmaceuticals, Inc. in Charlottesville, Virginia - EIN TaxId
Merand Pharmaceuticals, Inc. is a corporation in Charlottesville, Virginia. The employer identification number (EIN) for Merand Pharmaceuticals, Inc. is 825449957. EIN for …See details»
Merand Pharmaceuticals - Products, Competitors, Financials, …
Merand Pharmaceuticals is a healthcare pharmaceuticals company operating in stealth mode. Use the CB Insights Platform to explore Merand Pharmaceuticals's full profile. Merand …See details»
Merand Pharmaceuticals • UVA Licensing & Ventures Group
Merand Pharmaceuticals is developing a novel microRNA therapeutic to treat patients suffering from Peripheral Arterial Disease, a progressive circulatory issue affecting more than 200 …See details»
Merand Pharmaceuticals - 2025 Company Profile - Tracxn
Mar 11, 2025 Merand Pharmaceuticals - Developer of gene therapies for cardiovascular disorders. Raised funding from 1 investor. Founded by Tony Giordano and Brian Annex in the …See details»
Merand Pharmaceuticals - Crunchbase
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease.See details»
Merand Pharmaceuticals - Raised Funding from 1 investor - Tracxn
Mar 23, 2025 Carstay - Kanagawa based, raised a funding of $747K in Seed round held on Mar 11, 2025.; NovAccel - raised a funding of $1.36M in Seed round held on Mar 11, 2025.; Cloud …See details»
Technology - Merand Pharmaceuticals Inc.
Assignee: Merand Pharmaceuticals, Inc. Provision patent application US 63/148,940 filed on 2/12/2021, with PCT application filed in 2022. Company ready to initiate First-in-Human, …See details»
Merand Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...
Merand Pharmaceuticals's latest funding round was a Series A for $1.14M on July 23, 2019. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from …See details»
Merand Pharmaceuticals • UVA Licensing & Ventures Group
Merand Pharmaceuticals is developing a novel microRNA therapeutic (MicroRNA93 or miR-93), which was discovered at UVA, to treat patients suffering from Peripheral Arterial Disease …See details»
Merand Pharmaceuticals founders & board of directors - Tracxn
Jan 27, 2025 Brian Annex, Co-Founder at . Merand PharmaceuticalsView all Merand Pharmaceuticals Founders About the team at Merand Pharmaceuticals?Tony Giordano, Co …See details»
Peripheral vascular disease: preclinical models and emerging ...
Jun 17, 2021 BH Annex is the founder of Merand Pharmaceuticals which is seeking to develop microRNAs for PAD. VC Ganta received a grant from Merand Pharm. The authors have no …See details»
Merand Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Merand Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»